Further investigation highlighted that the Hippo pathway interacts with the AKT pathway by influencing insulin receptor substrate 2 (IRS2) expression in NAFLD, which affects the development of NAFLD and even HCC [11]. This evidence concerns the gene IRS2 and metabolic dysfunction-associated steatotic liver disease.